期刊文献+

子痫前期患者血浆YKL-40、IL-18和CRP水平变化及临床意义 被引量:5

The clinical significance and changes of serum levels of YKL-40,IL-18 and C-reactiveprotein in patients with preeclampsia
下载PDF
导出
摘要 选近3年40例健康孕妇和35例子痫前期患者,其中轻度子痫前期20例,重度子痫前期15例。采用夹心酶联免疫法检测血浆甲壳质酶蛋白-40(YKL-40)和白细胞介素-18(IL-18)水平;透射比浊法检测血清C反应蛋白(CRP)水平。通过分析子痫前期患者及正常孕妇血浆YKL-40、IL-18及CRP水平,探讨子痫前期的发生及严重性与炎症关系。结果表明:血浆YKL-40、IL-18和CRP水平在子痫前期孕妇明显高于正常孕妇(P<0.05);血浆YKL-40和IL-18水平在重度子痫前期孕妇明显高于轻度子痫前期孕妇(P<0.05);在重度子痫前期孕妇CRP水平与轻度子痫前期孕妇相比无明显差异(P>0.05)。YKL-40、IL-18和CRP水平在子痫前期明显升高,YKL-40和IL-18水平与子痫前期疾病的严重性相关。 Forty healthy pregnant women and thirty-five patients with preeclampsia (including 20 milder preeclampsia and 15 severe preeclampsia) were included in this study. Serum levels of YKL-40 and IL-18 were measured using an enzyme-linked immunosorbent assay (ELLSA) and turbidimetry-immunoassay was used to detect the levels of C-reactive protein. The aim of this study was to evaluate the relationship of serum levels of YKL-40, IL-18 and CRP with inflammatory in preeclampsia. The results were as follows:Serum YKL-40, IL-18 levels and CRP levels were significantly higher in patients with preeclampsia than those in normal pregnant women (P〈0.05) ; Moreover, higher serum YKL-40, IL-18 levels were observed in patients with more severe condition than in patients with milder condition (P〈0.05). There was, however, no significant difference in serum CRP levels between patients with more severe condition and those with milder condition (P〈0. 05). Conclusion: YKL-40, IL-18 and CRP were elevated in patients with preeclampsia and levels of YKL-40, IL-18 were related to the severity of the disease.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2013年第3期19-22,共4页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 国家自然科学基金资助项目(31371174) 江苏省自然科学基金资助项目(BK20131230)
关键词 子痫前期 YKL-40 IL-18 CRP 炎症 preeclampsia YKL-40 IL-18 CRP inflammatory
  • 相关文献

参考文献17

  • 1Estibalitz L S, Nardhy G L. The pathophysiology of preeclampsia involves altered levels of angiogenic factors pro- moted by hypoxia and autoantibody-mediated mechanisms [J]. Biol Reprod, 2012, 87: 36.
  • 2Henry N J, Kurt J S. Inflammatory pathways in female reproductive health and disease [J]. Reproduction, 2009, 138: 903-919.
  • 3孔祥,卢丹,汪萍,周甜甜.胎膜早破孕妇胎膜组织中NF-κB、COX-2和MMP-9的表达及意义[J].扬州大学学报(农业与生命科学版),2010,31(1):16-19. 被引量:5
  • 4Seol H J, Lee E S. Serum levels of YKI740 and interleukin-18 and their relationship to disease severity in patients with preeclampsia [J].Journal of Reproductive Immunology, 2009, 79: 183-187.
  • 5Sersam L W. Inflammatory markers in pre-eclampsia and related conditions [J]. Int J Gynaecol Obstet, 2009, 105(1) : 69-70.
  • 6Pennington K A, Schlitt J M, Jackson D L, et al. Preeclampsia.. multiple approaches for a multifactorial disease [J]. Dis Model Mech, 2012, 5: 9-18.
  • 7Sado T, Naruse K, Noguchi T, et al. Inflammatory pattern recognition receptors and their ligands: factors contrib- uting to the pathogenesis of preeclampsia [J]. Inflamm Res, 2011, 60(6): 509-520.
  • 8Holder B S, Tower C L, Jones C J, et al. Heightened pro-inflammatory effect of preeclamptic placental microvesi- cles on peripheral blood immune cells in humans [J]. Biol Reprod, 2012, 86: 103.
  • 9Yusuf Usttin, Yaprak Engin Usttin, Mansur Kamac. Association of fibrinogen and C-reactive protein with severi- ty of preeclampsia [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005, 121(2) : 154-158.
  • 10张俊,李荣国,毛海婷.妊娠高血压综合征患者血清C_3、C_4及CRP水平变化及意义[J].山东医药,2009,49(15):20-21. 被引量:13

二级参考文献19

  • 1胡志勤,盛丹菁,楼觉人,张天仁.正常孕妇及妊娠高血压综合征患者的补体系统研究[J].上海医学,1988(3):141-144. 被引量:4
  • 2陈汉平,黄引萍,马庭元.妊高征胎盘的免疫病理性损伤及类型[J].中华妇产科杂志,1996,31(9):540-542. 被引量:23
  • 3Redman WG, Sacks GP, Sargent I, et al. An excessive maternal inflammatory response to Pregnancy [ J ]. AmJ Obstct Gyneeol, 1999, 180 (1) :499-506.
  • 4Kilic-Okman T, Kueuk M, Ekuklu G. C-reactive proteinand body mass index in women with pre-eclampsia[ J]. Int J Gynaecol,2004, 84(1 ) :75-76.
  • 5Tjoa ML,van Vugt JM ,Co AT,et al. Elevated C-reactive protein levels during first trimester of pregnancy areindicative of preeclampsia and intrauterine growth restriction [J]. Reprod Immunol, 2003,59 (1) :29-37.
  • 6Chapman N R, Europe-Finner G N, RobsonS C. Expression and deoxyribonucleic acid binding activity of the nucle ar factor kappa B family in the human myometrium during pregnancy and labor [J]. Clin Endocrinol Metab, 2004, 89: 5683-5693.
  • 7Lappas M, Rice G E. The role and regulation of the nuclear factor kappa B signalling pathway in human labour [J].Placenta, 2007, 28: 543-556.
  • 8Xu Y, Knipp G T, Cook T J. Expression of cyclooxygenase isoforms in developing rat placenta, human term placenta, and BeWo human trophoblast model [J]. Mol Pharm, 2005, 2(6) : 481-490.
  • 9Olson D M, Ammann C. Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour [J]. Front Biosci, 2007, 12: 1329-1343.
  • 10Niesporek S, Weichert W, Sinn B, et al. NF-kappa B subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression [J]. Verh Dtsch Ges Pathol, 2007, 91: 243-249.

共引文献16

同被引文献67

  • 1谢辛,苟文丽.妇产:科学[M].北京:人民卫生出版社,2013:180-181.
  • 2Kumar P. Rajasekaran K, Palmer J M, et al. IL-22: an evolutionary missing-link authenticating the role of the im- mune system in tissue regeneration [J]. J Cancer, 2013, 4: 57-65.
  • 3Sa S M, Valdez P A, Wu J, et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis sug- gest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis [J].J lmmunol, 2007, 178:2229 -2240.
  • 4Wotk K, Wine E, Wallace E, et al. IL-22 regulates the expression of genes responsible for antimicrohial defense, cellular differentlation, and mobility in keralinocytes, a potential role in psoriasis [J]. Eur J Immunol, 2006, 36: 1309-1323.
  • 5Singh F, Gao D, I.ebwohl M G, et al. Shikonin modulates cell proliferation by inhibiting epidermal growth factor signaling in human epidermoid carcinoma eells [J]. Cancer Leu, 2003, 200:115- 121.
  • 6Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease [J]. Cytokine & Growth Factor Rev, 2010, 21: 435-441.
  • 7Btlchau A S, Gauo B L. Innate immunity and antimicrobial defense systems in psoriasis [J]. Clin Dermatol, 2007, 25(6) : 616-624.
  • 8Glaser R, Harder J, Lange H, et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection [J]. Nat Immunol, 2005, 6: 57-64.
  • 9Estibalitz Laresgoiti-Servitje. A leading role for the immune system in the pathophysiology of preeclampsia[J]. J Leukoc Biol, 2013,94(2) : 247-257.
  • 10Mygind ND, Lversen K, Kober L, et al. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality[J]. J Intern Med,2013,273(2) :205-216.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部